GIST - GASTROINTESTINAL STROMAL TUMOR
Clinical trials for GIST - GASTROINTESTINAL STROMAL TUMOR explained in plain language.
Never miss a new study
Get alerted when new GIST - GASTROINTESTINAL STROMAL TUMOR trials appear
Sign up with your email to follow new studies for GIST - GASTROINTESTINAL STROMAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced GIST: experimental drug NB003 enters Late-Stage trial
Disease control Not yet recruitingThis study tests a new drug called NB003 in people with advanced GIST (a type of stomach or intestinal cancer) that has worsened after standard treatments. The trial has two parts: one compares NB003 to another drug (regorafenib) for patients who have already tried two prior ther…
Matched conditions: GIST - GASTROINTESTINAL STROMAL TUMOR
Phase: PHASE2, PHASE3 • Sponsor: Ningbo Newbay Technology Development Co., Ltd • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
1000 GIST patients join global effort to unlock tumor secrets
Knowledge-focused Not yet recruitingThis study collects medical information and optional biological samples from 1000 people diagnosed with GIST, a rare digestive tract tumor. It does not test any new treatments or require extra visits. Researchers hope to better understand how GIST behaves, especially rare forms, …
Matched conditions: GIST - GASTROINTESTINAL STROMAL TUMOR
Sponsor: Universität Duisburg-Essen • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC